BioFluidica

BioFluidica, Inc. is a private biotechnology company that has developed a diagnostic platform allowing for disease management and diagnosis through simple blood tests. The BioFluidica diagnostic platform can precisely capture and isolate disease biomarkers, such as circulating tumor cells (CTCs), and has been clinically validated. We are able to scan blood for the earliest signs of disease, detecting the rarest biomarkers with unparalleled sensitivity, fulfilling the true promise of liquid biopsies. By bringing better diagnostic methods to millions, we are revolutionizing disease diagnosis.